HBV Citations List: October 2022

Literature Citations

1. Discovery and Antiviral Profile of New Sulfamoylbenzamide Derivatives as HBV Capsid Assembly Modulators. Ivanova Bencheva, L., L. Donnici, L. Ferrante, A. Prandi, R. Sinisi, M. De Matteo, P. Randazzo, M. Conti, P. Di Lucia, E. Bono, L. Giustini, M. Vittoria Orsale, A. Patsilinakos, E. Monteagudo, M. Iannacone, V. Summa, L.G. Guidotti, R. De Francesco, and R. Di Fabio. Bioorganic & Medicinal Chemistry Letters, 2022. 73: 128904. PMID[35868496].
[PubMed]. HBV_10_2022.

2. Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus. Ma, Y., S. Nakamoto, J. Ao, N. Qiang, T. Kogure, K. Ogawa, M. Nakagawa, K. Fujiwara, T. Iwanaga, R. Kojima, H. Kanzaki, K. Koroki, K. Kobayashi, N. Kanogawa, S. Kiyono, M. Nakamura, T. Kondo, R. Nakagawa, S. Ogasawara, R. Muroyama, T. Chiba, J. Kato, and N. Kato. International Journal of Molecular Sciences, 2022. 23(19): 12015. PMID[36233317]. PMCID[PMC9569680].
[PubMed]. HBV_10_2022.

Patent Citations

This month, no relevant HBV patents were identified.